Загрузка...
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
BACKGROUND: Globally, enteric-coated mycophenolate sodium (EC-MPS) is replacing mycophenolate mofetil (MMF) in maintenance immunosuppressant regimens. The predominant reason for conversion is the purported improvement in gastrointestinal (GI) quality of life. This paper considers the level of bias a...
Сохранить в:
| Опубликовано в: : | Drugs R D |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277323/ https://ncbi.nlm.nih.gov/pubmed/30426342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0254-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|